Huaizheng Peng currently serves as the Chief Business Officer at China Medical System Holdings Ltd since March 2022, with extensive experience in the pharmaceutical sector spanning over two decades. In addition to this role, Huaizheng Peng holds directorships at CMS Pharma and Bridging Pharma Ltd, and serves as Managing Director at TopRidge Pharma and CMS Medical Venture Investment Ltd, focusing on global asset acquisition and strategic investment in medical products. Previously, Huaizheng Peng was General Manager of International Operations and a Board Director at China Medical System Holdings Ltd, along with roles in investment management and corporate finance at various firms. Educational qualifications include a PhD in Molecular Pathology from UCL and medical degrees from Central South University.
Org chart
Sign up to view 1 direct report
Get started
Teams
This person is not in any teams
